Speaker Profile
Biography
Dr. Melody Smiths research is dedicated to improving outcomes for patients undergoing hematopoietic stem cell transplantation, with a particular focus on immune reconstitution and preventing graft-versus-host disease (GVHD). She explores innovative therapeutic strategies to enhance immune recovery and reduce post-transplantation complications. Dr. Smith earned her medical degree from the University of Tennessee College of Medicine and a Master of Science in Clinical Investigation from Northwestern University. Her research, published in respected journals, advances the field of cellular therapy, aiming to improve patient care and outcomes.
Session Abstract – PMWC 2025 Silicon Valley
Track 3 - February 7 9.00 A.M.-3.00 P.M.
Track Chairs:
Charles Chiu, UCSF
- PMWC 2025 Award Ceremony
Pioneer Honoree: Julie Louise Gerberding, FNIH
- Keynote: From Crisis to Cure: Navigating Public Health Challenges in the Era of Precision Diagnostics
- Julie Louise Gerberding, FNIH
- Harnessing Emerging Diagnostic Technologies in Primary and Critical Care (PANEL)
Chair: Mylynda Massart, UPMC
- Christopher Woods, Duke
- Helen Chu, U of Washington
- Yvonne Maldonado, Stanford
- Rose Lee, NIH - New Viral and Microbiome Associations with Cancer
Chair: Charles Chiu, UCSF
- Nancy Joseph, UCSF
- Melody Smith, Stanford
- Metagenomics and Partnerships: Monitoring Infectious Disease Threats
- Duncan MacCannell
- Adi V. Gundlapalli, CDC
- Mindy Nye, LabCorp - Innovative Therapeutics and Host-Pathogen Interactions in Infectious Disease Management (PANEL)
- Victor Nizet, UCSD
- Brad Spellberg, LA General Medical Center
- Nevan Krogan, UCSF
- Margaret Riley, University of Massachusetts